74 results about "Taurine" patented technology

This invention relates to a traditional Chinese medicine combination for treating intrahepatic cholestasis, which is made from the following raw materials in parts by weight: Artemisia capillaris and Glycyrrhiza uralensis 5:1 and 3:1. This invention also provides the preparation of the above-mentioned medicine and its use in treating intrahepatic cholestasis. Its advantages are: the traditional Chinese medicine composition of this invention (Artemisia capillaris and Glycyrrhiza uralensis decoction) has a significant ameliorative effect on intrahepatic cholestasis (non-obstructive type) induced by a 1% CA-containing diet in mice. Artemisia capillaris and Glycyrrhiza uralensis decoction can alleviate weight loss in mice and improve liver necrosis; significantly reduce serum ALT and ALP levels in mice; reduce the content of total bile acids in the liver and decrease the proportion of toxic bile acid taurine deoxycholic acid (TDCA) in the bile acid pool; upregulate liver BSEP protein expression to promote bile acid efflux; and downregulate liver NLRP3 protein expression to alleviate liver necrosis.

The application belongs to the technical field of molecular biology, and particularly relates to metabolic markers for evaluating the prognosis of patients with hypertrophic cardiomyopathy and application thereof. The application determines that one or more of 3-hydroxyrilotene, asparagine-lysine, cyclohexylamine, arachidonic acid, aconitic acid, propionyl carnitine, ceramide, tryptophan, 3-hydroxysebacic acid, traumatic acid, phosphatidylcholine, alanine-proline, lysophosphatidylcholine, taurine and S-garlicin cysteine are related to the prognosis of hypertrophic cardiomyopathy, can evaluate the prognosis of patients with hypertrophic cardiomyopathy after undergoing muscle resection of interventricular septum, and shows accurate judgment on all-cause death or rehospitalization, cardiovascular events and postoperative new-onset arrhythmia. Finally, all the prognostic biomarkers are reproduced in an independent cohort, which is helpful for postoperative risk evaluation of patients with hypertrophic cardiomyopathy, has high specificity and high sensitivity.

This invention discloses a pharmaceutical composition for treating asthenospermia by activating the Nrf2 / HO-1 / GPx4 pathway and its application. The pharmaceutical composition comprises taurine and geranium as active ingredients, wherein the mass ratio of taurine to geranium is 3-5:1. The pharmaceutical composition of this invention can synergistically activate the Nrf2 / HO-1 / GPx4 antioxidant signaling pathway, upregulate the expression of downstream antioxidant enzymes GPx4 and HO-1, inhibit lipid peroxidation, protect sperm mitochondrial function, and simultaneously improve the microenvironmental metabolic profile of the epididymis—the site of sperm maturation—thereby enhancing sperm motility. The pharmaceutical composition provided by this invention can be used to prepare a treatment for asthenospermia, particularly oxidative stress-induced asthenospermia.

The application provides a kind of composition for relieving fatigue and its preparation method, belong to relieving fatigue composition technical field.The composition for relieving fatigue of the application includes the following raw materials by mass concentration: Brazilian ginseng-guarana composite water extract 60%-70%, taurine 1%-2%, tea polyphenol 0.2%-0.4%, inositol 0.8%-1.2%, maltitol 1%-1.5%, erythritol 0.5%-1%, stevioside 0.05%-0.1%, citric acid 0.01%-0.02%, malic acid 0.01%-0.02%, vitamin C 0.1%-0.3%, xanthan gum 0.08%-0.12%, and the balance is water.In the composition of the application, Brazilian ginseng-guarana composite water extract provides ecdysterone, caffeine and other core substances, laying the foundation for anti-fatigue;Taurine cooperates to remove lactic acid and reduce serum urea accumulation, inositol regulates energy homeostasis, tea polyphenol and vitamin C strengthen antioxidant protection, and each component plays a synergistic anti-fatigue effect through complementation, and the active ingredients are stable, low-calorie, and excellent in taste.

FIELD: veterinary medicine and dietetics.SUBSTANCE: development of complete feed compositions that can provide a therapeutic effect in cases of exocrine pancreatic insufficiency. The composition of a complete dietary feed for cats with exocrine pancreatic insufficiency has been developed in the following ratio, wt.%: grain part: mixture of rice, wheat, hulled barley and corn – 37.0; protein part of plant origin: isolated soy protein, beet pulp, wheat bran, flax seeds – 22.0; protein part of animal origin: feather meal, chicken liver, egg powder – 25.0; mineral supplement: feed chalk, monocalcium phosphate, table salt, plantain seeds Plantago psyllium, mannanoligasaccharides with beta-glucans and lutein – 2.0; vitamin premix: A, D3, E, K, B1, B2, B3, B5, B6, B12, Bc, H, taurine, inulin, beech lignocellulose, complex of natural fulvic and humic acids – 2.5; flavor enhancer in the form of enzymatic hydrolysate of pork and chicken by-products – 3–3.5; brewer's yeast – 2.5–3.0; a mixture of fish and chicken fat – 5.0–6.0.EFFECT: obtaining food for cats with exocrine pancreatic insufficiency, which is easily reproducible, clinically effective, and convenient in dosing and use.1 cl, 3 tbl, 1 ex

This invention provides a liquid crystal biomimetic water-locking and oxygen-permeable skincare composition, its preparation method, and its application, belonging to the field of cosmetic technology. It comprises the following components by weight percentage: 20-40% glycerin, 5-10% hydrogenated lecithin, 5-10% phytosterols, 0.1-0.5% sodium stearoyl glutamate, 0.01-0.05% sodium methylstearoyl taurate, 0.1-1% ceramide NP, 1-10% caprylic / capric triglyceride, 1-10% squalane, 0.1-1% tocopheryl acetate, 0.01-0.3% sodium DNA, 0.001-0.1% fibronectin, 0.001-0.1% soluble collagen, and the balance being water. The liquid crystal biomimetic water-locking and oxygen-permeable skincare composition provided by this invention can better form a breathable protective film on the skin surface, reduce skin moisture loss, and help repair damaged skin barriers, thereby achieving the effect of water-locking and oxygen-permeable skincare.

Composition comprising a combination of oleuropein or metabolite thereof and taurine or functional derivative thereof are provided. The composition may be an oral nutritional composition, for example a nutritional supplement, an oral nutritional supplement, a food product, a food for special medical purpose (FSMP). The composition can be administered to an individual in need thereof for improving a physiological state linked to metabolic fatigue in one or more cells, (ii) increasing mitochondrial energy and mitochondrial calcium uptake in one or more cells, and (iii) increasing antioxidant capacity, reducing oxidative stress and / or enhancing mitochondrial function, (iv) treating or preventing a calcium deficiency / depletion disorder in an individual. Additionally or alternatively, the method can treat or prevent a mitochondria-related disease or a condition associated with altered mitochondrial function in an individual in need thereof or at risk thereof.

The present invention relates to a composition for preventing or treating periodontitis containing cannabidiol and taurine. The composition according to the present invention can effectively prevent or treat periodontitis by suppressing inflammatory factors and directly suppressing the loss of alveolar bone. In addition, it is safe for the human body and has almost no side effects, so it can be used in various ways as a material for medicines, quasi-drugs, or health functional foods.

An object of the present application is to provide a new composition for promoting ketogenesis. According to the present application, there is provided a composition for promoting ketogenesis containing one or two or more amino acids selected from the group consisting of citrulline, leucine, cysteine, taurine, glutamine and aspartic acid. The composition of the present application can further contain either or both of a medium-chain fatty acid and a medium-chain fatty acid ester.

The application belongs to the technical field of organic synthesis and specifically relates to a preparation process of high-efficiency taurine. The process specifically comprises the following steps: S1, raw material solution preparation and mother liquor threshold reuse; S2, construction of an aminolysis selective chemical environment; S3, aminolysis reaction; S4, deamination and clarification filtration; S5, segmented acidification-crystallization coupling; S6, crystal throwing and controlled cooling crystallization; S7, solid-liquid separation, washing and drying; and S8, mother liquor threshold detection and closed-loop reuse. The application constructs an aminolysis selective control, acidification-crystallization purification and mother liquor threshold reuse synergistic closed-loop process, stably controls a reaction system, dynamically determines an end point, and inhibits by-product generation from the source; segmented acidification and temperature-controlled crystallization are adopted to improve the purity of crystals and the first-time pharmaceutical-grade qualified rate; and the mother liquor is recycled according to a multi-index threshold access, thereby blocking impurity accumulation.

The present disclosure provides compositions and methods for providing a health benefit to a growing animal comprising administering a food composition to the animal, wherein the food composition includes a brain development blend. The brain development blend generally comprises DHA, EPA, taurine, choline, thiamine, riboflavin, pantothenic acid, niacin, pyridoxine, vitamin B12, and folic acid.

This invention relates to a specially formulated krill oil soft capsule composition designed to optimize fat energy supply and help reduce and delay lactic acid buildup, suitable for use in the food, nutritional supplement, health product, or sports supplement industries. The composition comprises the following ingredients by weight percentage: taurine (0-20%), sodium bicarbonate (0-20%), β-alanine (0-5%), citrulline malic acid (0-10%), with the balance being krill oil rich in Omega-3 polyunsaturated fatty acids. By rationally combining these ingredients, not only is the role of krill oil in promoting fat as an energy source enhanced, but the generation and clearance of lactic acid during exercise are also effectively managed, thereby supporting more sustained energy output and faster recovery. Furthermore, this invention provides a method for preparing the above composition and its application in improving athletic performance and accelerating recovery. This composition and its preparation method offer a new option for individuals seeking efficient energy management and physical recovery.

This utility model discloses a temperature control device for a taurine reactor, relating to the field of taurine processing technology. It includes a reactor, an air-cooled condenser, an electromagnetic descaling device, a refrigeration unit, a frozen brine tank, a frozen brine pumping system, a first screen filter, and a second screen filter. A refrigeration coil is coiled within the reactor's jacket. The outlet of the refrigeration coil, the air-cooled condenser, the electromagnetic descaling device, the refrigeration unit, the first screen filter, the frozen brine tank, the second screen filter, the frozen brine pumping system, and the inlet of the refrigeration coil are sequentially connected via refrigeration piping. A heating coil is also provided within the reactor's jacket. The inlet and outlet of the heating coil are connected to a heat transfer oil heating device via heating piping. This utility model's taurine reactor temperature control device has the advantages of good cooling effect and low energy consumption.

This invention relates to the field of pet product technology, specifically to a cat-specific nutritional pet food for shiny, strong, and healthy fur and its preparation method. This invention, through the compounding of vitamins, amino acids, oils, proteins, microorganisms, plant-derived nutrients, and a fur-strengthening additive, yields a nutritionally balanced food that promotes shiny, strong, and healthy fur in pets. The fur-strengthening additive is obtained by mixing fur-strengthening additive A and fur-strengthening additive B. Fur-strengthening additive A directly provides the substances needed for hair growth, improves the pet's hydration, promotes healthy fur, and effectively enhances the pet's immunity and disease resistance. In fur-strengthening additive B, coenzyme Q10-ovalbumin amyloid fiber complex works synergistically with vitamin 6 and taurine to effectively reduce free radical damage, delay cell aging, and thus improve hair quality and health, showing broad application prospects.

The present application provides a kind of nutrition composition which is helpful to lubricate intestine and defecate, which is composed of natto, red rice, taurine, vitamin B1, vitamin B2 and acceptable adjuvant in specific content ratio.The present application has the advantages that: the composition has synergistic effect, can lubricate intestine and defecate, is used for preventing or assisting treatment of functional constipation, and has small side effect and does not produce dependency.In addition, the compound form of the product can significantly improve the compliance of the user population and save the overall use cost.

This invention provides a high-temperature stable fluorinated carbon oil displacement surfactant and its preparation method, belonging to the field of surfactant technology. This application constructs a triazine fluorinated surfactant: First, 1H,1H,2H,2H-perfluorooctane-1-ol is used in the presence of anhydrous potassium carbonate to generate a fluorinated alkoxy anion, which forms a C-O bond with cyanuric chloride, introducing a fluorinated hydrophobic arm; then, sodium N-methyltaurate is introduced to N-substitute the unsubstituted chlorine position, introducing a sulfonate hydrophilic head group, obtaining an intermediate of a fluorinated hydrophobic arm and a taurine hydrophilic arm; then, oleylamine is used to replace the remaining chlorine position, introducing a long-chain hydrocarbon hydrophobic arm, forming a surfactant mixture with an O-N-N triazine structure consisting of a "fluorinated alkoxy arm-taurine hydrophilic arm-oleylamine hydrocarbon arm"; after solvent removal and addition to an ethylene glycol monobutyl ether / water co-solvent system, a stable oil displacement surfactant that is easy to prepare and use on-site is obtained.

This invention belongs to the field of biomedicine or food technology, specifically relating to a compound wine with anti-tumor effects. The main raw materials of this composition are N-acetyl-D-glucosamine and taurine, wherein the weight ratio of N-acetyl-D-glucosamine to taurine is 19.5-20.5:2.9-3.1. Studies have shown that when the proportion of taurine in the composition exceeds a certain level, the stability of N-acetyl-D-glucosamine decreases, while when the proportion of taurine in the composition is reduced to a certain level, the two do not have a synergistic effect in the anti-tumor model.

This invention relates to nutritional compositions and their uses. Specifically, this invention relates to a nutritional composition comprising: (1) component A consisting of docosahexaenoic acid and arachidonic acid; (2) component B consisting of medium- and long-chain fatty acid triglycerides and 1,3-dioleoyl-2-palmitoyl triglycerides; and (3) component C consisting of choline and taurine. This invention also relates to the use of this nutritional composition for non-therapeutic purposes, including: promoting neurotransmitter expression; improving neuronal structure and function; and improving anxiety. This invention further relates to the use of this nutritional composition in the preparation of products for non-therapeutic purposes, including improving brain development and / or memory and / or improving anxiety. The nutritional composition of this invention can significantly improve brain development and / or memory and / or improve anxiety, which is beneficial for meeting current market demands.

The present application belongs to the field of aquaculture and nutrition regulation technology, and particularly relates to a ursodeoxycholic acid preparation for inducing the group behavior of juvenile fish, a preparation method and application. The ursodeoxycholic acid preparation for inducing the group behavior of juvenile fish is composed of ursodeoxycholic acid and additives equivalent to 0% to 2% of the mass of ursodeoxycholic acid; the additives are cholic acid or a mixed agent, and the mixed agent is a mixture of taurine and tryptophan in a mass ratio of 1:1. After the ursodeoxycholic acid preparation for inducing the group behavior of juvenile fish is used to feed large yellow croaker juveniles, the juvenile fish olfaction can be stimulated, the group behavior of the juvenile fish can be induced, the growth of the large yellow croaker juveniles can be promoted, the metabolism can be promoted, and the immunity can be improved.

A nutritional composition, a preparation method therefor, and uses thereof are provided. The nutritional composition has the following raw materials in the pre-determined mass ratios: 257-295 parts of proteinaceous substances, 383-395 parts of fatty substances, 632-770 parts of carbohydrates, 58-60 parts of dietary fiber substances, 4.7-5.6 parts of complexed trace minerals, 106-119 parts of complexed major minerals, 10.7-12.9 parts of multi-vitamins, 6.21-7.62 parts of choline bitartrate, 0.986-1.1 parts of L-carnitine, and 0.42-0.762 parts of taurine.

The present application relates to the technical field of feed additive, in particular to a kind of compound additive for improving lactation of sow and its preparation method and application, the compound additive is the polysaccharide skeleton of xanthan gum and konjac glucomannan, and active component is loaded in the polysaccharide skeleton inside;Wherein, the active component includes organic acid, prebiotic, functional amino acid, compound mineral, grass juice concentrate and fish solution.The present application has the advantages that polysaccharide skeleton microspheres are prepared by compounding xanthan gum and konjac glucomannan, which can realize low release of active ingredients in stomach, high release in intestinal tract, and help to improve the utilization efficiency of active ingredients.The combination of fructo-oligosaccharides, taurine and arginine plays a role in intestinal health, antioxidant, mammary blood vessel dilation and milk protein synthesis, etc., forming a synergistic lactation effect.Microspheres embedding has a protective effect on water-soluble components such as fructo-oligosaccharides, taurine and arginine, which can reduce their loss during feed processing and storage.The raw materials of the present application are all of natural origin, which meets the requirements of green feed additive.

The specification describes a composition comprising an improved eukaryotic cell culture medium, which can be used for the production of a protein of interest. Taurine can be added to serum-free media or chemically-defined media to increase the production of a protein of interest. Methods for recombinantly expressing high levels of protein using the media compositions are included. 20 24 20 41 27 18 J un 2 02 4 A B S T R A C T 2 0 2 4 2 0 4 1 2 7 1 8 J u n 2 0 2 4

The specification describes a composition comprising an improved eukaryotic cell culture medium, which can be used for the production of a protein of interest. Taurine can be added to serum-free media or chemically-defined media to increase the production of a protein of interest. Methods for recombinantly expressing high levels of protein using the media compositions are included. 20 24 20 41 25 18 J un 2 02 4 A B S T R A C T 2 0 2 4 2 0 4 1 2 5 1 8 J u n 2 0 2 4

FIELD: food industry.SUBSTANCE: intended for preventive nutrition of individuals experiencing increased psycho-emotional stress. A drink concentrate is proposed to reduce psycho-emotional stress and maintain cognitive stability, which is made on the basis of biologically active components in the form of amino acids L-theanine, taurine and glycine, vitamins of group B-B1, B6 and B12, magnesium citrate, plant extracts of lemon balm and rose hips, β-glucan, ascorbic and succinic acids, stevia sweetener and water, and is made in two phases by combining the aqueous and lipophilic phases and homogenizing the prepared components, while the amino acids L-theanine, taurine and glycine are used in microencapsulated form with a polysaccharide shell based on maltodextrin and sodium alginate and with B vitamins and magnesium citrate are introduced during the preparation of the aqueous phase, and plant extracts of lemon balm and rose hips and β-glucan – in the preparation of a lipophilic phase stabilized with plant emulsifiers, while the total content of biologically active components per 20 ml of concentrate is selected within the range: L-theanine – 100–200 mg, taurine – 400–600 mg, glycine – 600–1000 mg, magnesium citrate – 300–500 mg, vitamin B1 – 1.5–2.5 mg, vitamin B6 – 1.5–2.5 mg, vitamin B12 – 0.001–0.003 mg, lemon balm herbal extract – 200–400 mg, rosehip herbal extract – 200–300 mg, ascorbic acid – 80–120 mg, succinic acid – 100–200 mg, β-glucan – 0.1–0.5 wt.%, stevia sweetener – 10–30 mg. In this case, before introducing biologically active components, the water is subjected to ultrasonic treatment at a frequency of 20–40 kHz for 3–5 minutes.EFFECT: increasing the bioavailability and stability of active substances, prolonged physiological action and reducing the effects of psycho-emotional stress.2 cl, 3 ex

This invention belongs to the field of biopharmaceutical technology, specifically relating to a composition for preventing and improving Alzheimer's disease and its preparation method. The composition is prepared by the following method: (S1) adding phosphatidylserine, an emulsifier, and walnut peptides to walnut paste to obtain an oil phase; (S2) dissolving xylitol, whole milk powder, and taurine in water, and slowly adding the oil phase during homogenization to obtain a mixed solution; (S3) dissolving a stabilizer in water to obtain a stabilizer solution, adding the stabilizer solution to the mixed solution, adding water to make up to volume, mixing thoroughly, and homogenizing to obtain the composition for preventing and improving Alzheimer's disease. This invention avoids the precipitation phenomenon caused by the Maillard reaction of walnut peptides. The antioxidant components in walnut paste can prevent the oxidative degradation of phosphatidylserine, solving quality problems such as oxidative rancidity and fat stratification in walnut paste, improving the stability of the composition, extending the shelf life of the product, and enhancing the product's competitiveness.

This invention relates to the field of infant formula technology, and discloses an infant formula milk powder and its preparation method. The infant formula milk powder is obtained by mixing demineralized whey powder, whey protein powder, fructooligosaccharides, choline chloride, taurine, fat molecule inclusion complex, complex mineral casein phosphopeptide chelate, water-soluble vitamin premix, and fat-soluble vitamin premix. The complex mineral casein phosphopeptide chelate is prepared from casein phosphopeptide, deionized water, sodium hydroxide aqueous solution, vitamin C, calcium citrate, ferrous sulfate, and zinc sulfate. The fat molecule inclusion complex is prepared from β-cyclodextrin, deionized water, walnut oil, docosahexaenoic acid, and anhydrous ethanol. This invention can delay the oxidation of unsaturated fatty acids in infant formula.

This invention discloses a sports nutrition nano-oral liquid, its preparation method, and its application, belonging to the field of food technology. The sports nutrition nano-oral liquid contains components such as vitamin C, vitamin E, taurine, calcium β-hydroxy-β-methylbutyrate, DHA algal oil, N-acetylglucosamine, a mixture of peanut peptides and yak bone collagen peptide powder, etc., and is prepared by oil-water dispersion, high-speed homogenization, and high-pressure microfluidic homogenization using caprylic / capric triglyceride as an auxiliary emulsifier. The use of caprylic / capric triglyceride as an auxiliary emulsifier, combined with microfluidic technology, achieves nanoscale dispersion of active ingredients, improving stability and bioavailability. The peptides, taurine, calcium β-hydroxy-β-methylbutyrate, DHA algal oil, and other components contained in the oral liquid can effectively relieve fatigue and promote recovery.

The present application relates to a composition with improved sleep quality function and its preparation method, belonging to the technical field of cosmetics and external preparation. The composition comprises: gamma-aminobutyric acid, isosorbide dimethyl ether, plant extract compound (pink passion fruit, jujube kernel, polygala, rehmannia), aromatic essential oil (lavender oil, dalbergia odorifera oil, linaloe extract), menthol, polyacryl dimethyl ammonium taurate and moisturizing and preservative system. By using isosorbide dimethyl ether and gamma-aminobutyric acid to form a penetration precursor solution, the problem of transdermal difficulty of gamma-aminobutyric acid is solved; and through a specific preparation process, a gradient sleep-aiding release based on the volatility difference of essential oil and gel wrapping is constructed, realizing the phased sleep-aiding effect of instant cooling to block irritability, induction of relaxation synergistic effect, and whole night slow release to maintain deep sleep. The composition has high transdermal absorption rate, controllable aroma release timing, long-lasting sleep-aiding effect, and good application prospect.